美股异动 | 2026财年业绩指引低于预期 波士顿科学(BSX.US)大跌超15%

Group 1 - Boston Scientific (BSX.US) experienced a significant drop of over 15%, marking its largest intraday decline since March 2020, with shares currently priced at $77.80 [1] - The company's fiscal year 2026 guidance indicates an adjusted earnings per share expectation of $3.43 to $3.49, slightly below the analyst average estimate of $3.47 [1] - The projected annual sales for the company are expected to be between $22.181 billion and $22.383 billion, which is lower than the analyst average forecast of $22.368 billion [1]